Your browser doesn't support javascript.
loading
The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters.
Shytaj, Iart Luca; Fares, Mohamed; Gallucci, Lara; Lucic, Bojana; Tolba, Mahmoud M; Zimmermann, Liv; Adler, Julia M; Xing, Na; Bushe, Judith; Gruber, Achim D; Ambiel, Ina; Taha Ayoub, Ahmed; Cortese, Mirko; Neufeldt, Christopher J; Stolp, Bettina; Sobhy, Mohamed Hossam; Fathy, Moustafa; Zhao, Min; Laketa, Vibor; Diaz, Ricardo Sobhie; Sutton, Richard E; Chlanda, Petr; Boulant, Steeve; Bartenschlager, Ralf; Stanifer, Megan L; Fackler, Oliver T; Trimpert, Jakob; Savarino, Andrea; Lusic, Marina.
Afiliación
  • Shytaj IL; Department of Infectious Diseases, Integrative Virology, Heidelberg University, Heidelberg, Germany.
  • Fares M; Federal University of São Paulo, Infectious Diseases Department, São Paulo, Brazil.
  • Gallucci L; Department of Hydrobiology, Veterinary Research Division, National Research Centre, Cairo, Egypt.
  • Lucic B; Center for Informatics Science (CIS), Nile University, Sheikh Zayed City, Giza, Egypt.
  • Tolba MM; Department of Infectious Diseases, Integrative Virology, Heidelberg University, Heidelberg, Germany.
  • Zimmermann L; Department of Infectious Diseases, Integrative Virology, Heidelberg University, Heidelberg, Germany.
  • Adler JM; German Center for Infection Research (DZIF), Heidelberg, Germany.
  • Xing N; Pharmaceutical Division, Ministry of Health and Population, Faiyum, Egypt.
  • Bushe J; Department of Infectious Diseases, Virology, CIID, Heidelberg University Hospital, Heidelberg, Germany.
  • Gruber AD; Schaller Research Groups, Center of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany.
  • Ambiel I; Institut für Virologie, Freie Universität Berlingrid.14095.39, Berlin, Germany.
  • Taha Ayoub A; Institut für Virologie, Freie Universität Berlingrid.14095.39, Berlin, Germany.
  • Cortese M; Institute of Veterinary Pathology, Freie Universität Berlingrid.14095.39, Berlin, Germany.
  • Neufeldt CJ; Institute of Veterinary Pathology, Freie Universität Berlingrid.14095.39, Berlin, Germany.
  • Stolp B; Department of Infectious Diseases, Integrative Virology, Heidelberg University, Heidelberg, Germany.
  • Sobhy MH; Biomolecular Simulation Center, Department of Pharmaceutical Chemistry, Heliopolis University, Cairo, Egypt.
  • Fathy M; Department of Infectious Diseases, Molecular Virology, CIID, Heidelberg University, Heidelberg, Germany.
  • Zhao M; Department of Infectious Diseases, Molecular Virology, CIID, Heidelberg University, Heidelberg, Germany.
  • Laketa V; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Diaz RS; Department of Infectious Diseases, Integrative Virology, Heidelberg University, Heidelberg, Germany.
  • Sutton RE; Biomolecular Simulation Center, Department of Pharmaceutical Chemistry, Heliopolis University, Cairo, Egypt.
  • Chlanda P; Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia, Egypt.
  • Boulant S; Department of Regenerative Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
  • Bartenschlager R; Yale School of Medicine, Department of Internal Medicine, Section of Infectious Diseases, New Haven, Connecticut, USA.
  • Stanifer ML; German Center for Infection Research (DZIF), Heidelberg, Germany.
  • Fackler OT; Department of Infectious Diseases, Virology, CIID, Heidelberg University Hospital, Heidelberg, Germany.
  • Trimpert J; Federal University of São Paulo, Infectious Diseases Department, São Paulo, Brazil.
  • Savarino A; Yale School of Medicine, Department of Internal Medicine, Section of Infectious Diseases, New Haven, Connecticut, USA.
  • Lusic M; Department of Infectious Diseases, Virology, CIID, Heidelberg University Hospital, Heidelberg, Germany.
mBio ; 13(2): e0370521, 2022 04 26.
Article en En | MEDLINE | ID: mdl-35229634

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Hepatitis C Crónica / Tratamiento Farmacológico de COVID-19 Límite: Animals / Humans Idioma: En Revista: MBio Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Hepatitis C Crónica / Tratamiento Farmacológico de COVID-19 Límite: Animals / Humans Idioma: En Revista: MBio Año: 2022 Tipo del documento: Article País de afiliación: Alemania